HomeKRYS • NASDAQ
add
Krystal Biotech Inc
Previous close
$159.47
Day range
$162.00 - $167.23
Year range
$86.03 - $189.97
Market cap
4.66B USD
Avg Volume
272.32K
P/E ratio
86.71
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 45.25M | — |
Operating expense | 37.02M | 1.91% |
Net income | 932.00K | 102.06% |
Net profit margin | 2.06 | — |
Earnings per share | 0.46 | 126.08% |
EBITDA | 6.38M | 118.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 538.26M | 53.62% |
Total assets | 853.30M | 60.44% |
Total liabilities | 54.05M | 27.84% |
Total equity | 799.24M | — |
Shares outstanding | 28.56M | — |
Price to book | 5.69 | — |
Return on assets | 1.74% | — |
Return on capital | 1.82% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 932.00K | 102.06% |
Cash from operations | 15.89M | 160.74% |
Cash from investing | -25.98M | -829.16% |
Cash from financing | 10.58M | 617.98% |
Net change in cash | 678.00K | 103.20% |
Free cash flow | 18.70M | 277.53% |
About
Founded
2015
Headquarters
Website
Employees
229